Biotinylation creates a sensitive and specific tag for purification and detection of target proteins.
Introduction
Biotinylation of biomolecules is widely used in biomedical sciences due to the high affinity binding of biotin to streptavidin and its homologues, which creates a simple and effective tag for purification and detection of targets molecules. Proteins can be biotinylated through chemical or enzymatic techniques. The chemical techniques are simple; however, they modify a broad range of chemically similar groups and therefore often lack target selectivity. Enzymatic biotinylation, on the other hand, is highly specific and is catalyzed by protein-biotin ligases. All living organisms express protein-biotin ligases, which biotinylate between 1-5 specific proteins in their respective organisms. 1 The E. coli protein-biotin ligase BirA is extremely specific and covalently attaches biotin to a single lysine in the endogenously expressed BCCP subunit of acetyl-CoA carboxylase. 2 Additionally, a small synthetic 15-amino-acid peptide is effectively biotinylated by BirA 3, 4 and fusion of the synthetic biotin acceptor peptide (AP) to a target protein creates an efficient approach for site-specific in vivo and in vitro biotinylation through co-expression or addition of BirA. [5] [6] [7] Although the high specificity and activity of BirA towards the synthetic AP provide a powerful approach for specific labeling, the range of applications for BirA mediated biotinylation is restricted to samples containing AP-fused proteins. Development of novel BirA variants with specificity towards peptide sequences that are present in endogenously expressed proteins would therefore massively expand the application range wherein enzymatic biotinylation can be utilized.
Directed evolution is a powerful method to evolve new protein function and involves iterations of gene mutations, isolation and amplification of gene variants with the desired function. BirA activity is readily selected and phage display technologies have been developed that allow for selection of BirA activity based on their display of biotinylated peptides. 8, 9 The strong binding of biotin to streptavidin ensures that even low abundant phages are selected, but the amplification of phages requires that they infect a bacterial host. The phages displaying the biotinylated peptides thus have to be eluted from the affinity resin, which creates a bottleneck. Instead, low affinity monomeric avidin has been used to allow for reversible binding of biotinylated phages and elution with biotin, 8, 9 ; however, it only allowed for a modest ~10-fold enrichment of BirA from phages expressing synthetic AP. 8 To accelerate the identification of active BirA variants, we sought to develop a selection method in which the elution step could be eliminated.
Bacteria can be selected and enriched through magnetic beads isolation with no need for elution 10 , and we therefore based our selection on a bacterial display system. As scaffold for peptide display, we used eCPX (enhanced circularly permuted outer membrane protein OmpX), which allow for effective display of peptides at both N-and C-termini. 11, 12 The target peptide sequence is inserted into the carboxy-terminus of eCPX 12 such that bacteria expressing active BirA variants biotinylate and subsequently display the biotinylated peptide on the surface, allowing for effective streptavidin selection ( Figure 1a ). Here, we demonstrate that bacterial display of a peptide sequence is an effective approach to select for BirA variants with novel specificity.
Results

Model selection of BirA against the synthetic AP
We generated a single plasmid in which BirA with a C-terminal 6xHis tag (BirA-6xHis) was controlled by an arabinose-inducible promoter (araBAD) and eCPX expression was controlled by a T7 promoter, allowing for induction of BirA-6xHis and eCPX expression using arabinose and isopropyl β-D-1-thiogalactopyranoside (IPTG), respectively ( Figure 1b ). The principle of the selection system is that a library of BirA mutants is co-expressed with eCPX fused to target peptide sequence and bacteria displaying biotinylated target peptide are readily selected and amplified while bound to the streptavidin beads ( Figure 1c ). We carried out a model selection using the BirA against its synthetic 15-amino-acid AP or its non-biotinylatable K10A sequence (AP(K10A)) 7 .
Biotinylated eCPX-AP was detected in uninduced cultures (Figure 2a ), indicating a low basal expression of the eCPX-AP from the T7 promoter even in the absence of IPTG and sequent biotinylation by endogenous BirA. BirA-6xHis was detected in cultures of eCPX-AP and -AP(K10A) after co-induction with arabinose and IPTG, but strong biotinylation was only detected in the eCPX-AP bacteria and not in BirA-eCPX-AP(K10A) (Figure 2a ).
The IPTG-and arabinose-induced bacteria were incubated with streptavidin-Dynabeads.
Immediately upon addition of streptavidin-Dynabeads to cultures, aggregation and precipitation of the streptavidin-Dynabeads was observed in the culture with eCPX-AP, but not in eCPX-AP(K10A) ( Figure 2b ). Western blot of the isolated streptavidin-Dynabeads incubated with bacteria displaying the synthetic AP showed intense biotinylation of eCPX-AP as well as isolation of BirA-6xHis, while both proteins were undetected in western blots of the streptavidin pull-down from eCPX-AP(K10A) ( Figure 2c ). In agreement, streptavidin precipitated viable bacteria to a higher degree in eCPX-AP cultures compared to eCPX-AP(K10A) ( Figure 2d ). Thus, the results suggest that bacteria display biotinylated eCPX on surface and allows for isolation of the biotinylated AP.
It is imperative that the selection procedure can isolate rare functional clones in the library and we therefore tested if eCPX-AP clones could be isolated after dilution into cultures of nonbiotinylatable eCPX-AP(K10A) at ratios of 1:10 3 , 1:10 6 , and 1:10 9 . After 2 rounds of selection, a strong enrichment of bacteria was observed in the mixed cultures containing eCPX-AP diluted 1:10 3 and 1:10 6 with cultures of eCPX-AP(K10A) bacteria, whereas no enrichment was detected in the cultures consisting of 1:10 9 dilution or cultures of pure eCPX-AP(K10A) (Figure 2e ). The AP/ AP(K10A) region of the plasmid was sequenced in 5 individual clones to estimate the enrichment factor. The enrichment for eCPX-AP in the 1 st selection round was the highest and estimated to be in the order of 10 6 ( Table 1 ), suggesting that the proposed selection scheme allows for the isolation of rare variants in a BirA library.
Selection of BirA variants biotinylating novel acceptor peptides
We tested if the selection scheme allowed for isolation of BirA variants that biotinylate peptide sequences present in unmodified proteins. Lysine-containing peptide sequences from 4 different subunits from membrane proteins were tested: Na + /K + -ATPase α1 (Figure 3a The intensity of the band was lower than that of the positive control, indicated that the isolated clones had lower activity towards the peptide sequence than BirA-6xHis had towards the synthetic AP. Moreover, we observed additional streptavidin-reacting bands with a higher molecular weight in some isolated clones expressing peptide sequences derived from Na + /K + -ATPase ( Figure 3a ) and γENaC (Figure 3d ), indicating the isolated BirA variants had a different specificity. We tested an additional 9 peptides sequences derived from different proteins. Bacteria displaying a peptide sequences from enhanced green fluorescent protein (EGFP) did not produce an enrichment even after 4 selection rounds ( Figure 4a ); however, a strong enrichment was detected for the remaining displayed peptide sequences after 3-5 rounds of selection (Figure 4b -i). Thus, bacterial display systems allow for selection of BirAs with novel specificity.
Biotinylation of TagRFP
We next tested if BirA variants selected for biotinylation of specific peptide sequence, could also Expression of BirA-6xHis caused a strong biotinylation of eCPX-AP, but no biotinylation product was detected at the expected size of MBP-TagRFP (Figure 5d ). In contrast, biotinylated bands at 75 kDa were detected after incubation of MBP-TagRFP and MBP-TagRFPK235 lysates with Clone 1, and the intensity of this band was strongly reduced by a mutation of K231A and K231A,235A in TagRFP (Figure 5d ). Similar to the clones isolated from bacteria expressing peptides from Na + /K + -ATPase α1 subunit, as well as the αENaC, βENaC and γENaC subunits, the intensity of the 75 kDa bands were low compared to the intensity of the eCPX-AP band from the BirA-6xHis expressing bacteria. The results, however, indicate that BirA selected with the bacterial display system allows for biotinylation of a specific protein in complex mixtures.
Potential targets
Specific protein biotinylation could provide a novel approach for purification and imaging of target proteins in complex mixtures, and we analyzed a total number of 16966 mouse proteins and 20316 human proteins for their lysine abundance. Only 54 mouse proteins (0.3%) and 111 human proteins (0.5%) did not contain lysine in their primary sequence, and the majority of mouse and human proteins contained 1 or more lysine(s) per protein ( Figure 6a ). Since structural restrains might limit BirA's ability to biotinylate its target protein, we restricted our analysis to the initial and terminal This indicates that directed evolution of BirA could potentially be used to produce a broad range BirA variants that biotinylates specific proteins in complex mixtures.
Discussion
Using a bacterial display system, we have demonstrated that bacteria expressing BirA variants can be selected for their ability to biotinylate specific peptide sequences and that the system allows for strong enrichment of active clones by streptavidin pulldown and direct amplification of the streptavidin-bound bacteria. The bacterial display system, thus, provides a basis for directed evolution of BirA variants with activity targeted towards specific target proteins. Almost all human and mouse proteins contain lysines and novel BirA variants could provide an attractive means for site-specific protein biotinylation in complex mixtures and thereby provide a high affinity tag for downstream purification or imaging of specific proteins of interest. The bacterial selection system effectively isolated BirA-6xHis activity against the synthetic AP diluted 10 6 -fold in cultures of bacteria displaying a mutated AP. The enrichment is orders of magnitude higher than previously reported for the phage display systems using monomeric avidin selection, 8 indicating that the higher affinity of streptavidin increase the stringency of the selection process. Streptavidin selection of phages displaying biotinylated peptides has been used to identify novel peptide substrates for yeast biotin protein ligase, and yielded an estimated enrichment factor of ~2000 and the streptavidin-bound phages were eluted by incubation at high temperatures. 13 The strong biotin-streptavidin binding combined with the multivalency of the displayed peptide (~5 peptides are displayed per phage 14 ) ensure isolation of rare active variants, but the high avidity still poses a problem in that incomplete elution of the isolated phages could hamper enrichment. The bacterial display system may have an advantage in that the elution can be eliminated and therefore allows for high affinity selection. The bacterial display system allowed for the isolation of clones with novel peptide substrate specificity. Compared to the BirA biotinylation of the synthetic AP, 3 however, our isolated clones showed relatively low activity towards the displayed peptide sequences. For directed evolution of our isolated BirA variants, it will be important to select for biotinylation rate by increasing selection presure through e.g. lowered expression of BirA, shorter reaction time or by using fluorescent activated cell sorting of bacteria labeled for surface biotinylation. In addition to reaction rate, the target specificity of the selected BirA variants are import. Our selection scheme does not include a negative selection step, e.g. removal of BirA varants with promiscuous activity, and we observed that some clones isolated from the display of peptides from Na + /K + -ATPase α1 subunit and γENaC (K27) biotinylated additional bands. Promiscuous BirA activity is, however, readily detected by western blotting and the specific and promiscuous BirA variants could be used as precursors for novel BirA variants, which through e.g. DNA shuffling 15 could be used to evolve BirA variants that biotinylates native proteins in vivo in e.g. mammalian cells.
In addition to its use as an affinity tag, site-specific biotinylation could potentially be used as organelle-specific in vivo inhibitors of post-translational modifications. Proteolytic cleavage at specific sites in the αand γ-subunits of the epithelial sodium channel (ENaC) activates the channel. [16] [17] [18] We have previously developed a monoclonal antibody directed against the neo-epitope created after proteolytic cleavage at a site corresponding lysine-186 of γENaC; 19 however, the antibody does not allow for testing the functional consequences of organelle-specific inhibition of cleavage. We isolated BirA variants against lysine 184, 186 and 190, which could serve as precursors for development of highly activate variants that could be targeted to the lumen of the endoplasmic reticulum, Golgi apparatus and endosomes and establish in which compartment the activation occurs. Thus, the expression of the BirA variants in specific cellular organelles could provide novel spatially restricted inhibitors of post-translational modifications, such as proteolytic cleavage and ubiquitination. The selection system is not limited to BirA and could potentially be used to select for other enzymes that carries out post-translational modification, such as kinases and ubiquitinases, and allow for development of novel tools to dissect signaling pathways.
In summary, BirA variants with novel peptide substrate specificity are readily isolated using the bacterial display system. The isolated BirA variants can be used as a starting point for directed evolution to select for highly effective clones, providing tools for effective detection and isolation of endogenously expressed proteins of interest in complex in vivo and in vitro environments.
Methods
Constructs
The coding sequence for BirA was synthesized by Genescript and cloned into pBAD/TOPO ThioFusion. eCPX wa synthesized by GeneArt and cloned into pF1K T7 (Promega). The region covering T7 promotor, eCPX and T7 termination was amplified by PCR and inserted into the PCR 
In vitro biotinylation
Lysates from BirA-TagRFP clone 1 and bacteria expressing TagRFP variants were mixed in a ratio of 1:1, supplemented with 3 µM biotin and incubated at room temperature.
Western blotting
Bacterial lysates were mixed with LDS samples buffer (ThermoFischer Scientific) and Reducing agent (ThermoFischer Scientific) at heated for 5 min at 95 °C. The samples were loaded on 10% SDS-PAGE gels (Biorad) and run at 200V. The proteins were electroblotted onto PVDF membranes for 2h at 350 mA, and the membrane was subsequently blocked in 5% skim milk (Sigma Aldrich) in PBS supplemented with 0.05% Tween-20 (PBST) for 1 h. Biotinylation was detected by probing the membrane with streptavidin-HRP (Dako) diluted 1:1000 in PBST. MBP was detected with anti-MBP (1:5000, New England Biolabs) and secondary goat anti-mouse HRP conjugated antibody (Dako).
Bioinformatics
The TagRFP structure was predicted using I-TASSER 20 and analyzed using Swiss-PdbViewer 21 .
Reviewed mouse and human protein sequences were downloaded from UniProt 22 and analyzed for lysine content using Python 2.7.
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary Information files). 
Table legend
The displayed AP region was sequenced in 5 randomly selected clones from the 1 st and 2 nd selection round from the cultures mixed at a AP:AP(K10A) ratio of 1:10 3 and 1:10 6 . The enrichment was calculated as [output AP:AP(K10A) ratio]/ [input AP:AP(K10A) ratio]. 
Figure legends
